first large study of glp 1 receptor agonists during pregnancy Taking GLP-1s the trimester does not appear to substantially increase the risk of adverse outcomes The hidden impact of GLP‐1
Description
In the U.K., Mounjaro is not yet recommended due to lack of sufficient evidence on efficacy and cost-effectiveness
ClinicalTrials.gov (2022)
Mol Cell Endocrinol 2001
Many programs now offer hands-on injection training sessions, digital video tutorials, and real-time pharmacist support to improve patient confidence
